These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15176703)

  • 1. Interferon therapy: the other face of the medal.
    Licata A; Craxì A
    Ann Ital Med Int; 2004; 19(1):5-7. PubMed ID: 15176703
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event?
    Salvio A; Mormile M; Giannattasio F; Varriale M; d'Errico T; Balzano B; Carratù P; Tufano G; Visconti M
    Ann Ital Med Int; 2004; 19(1):58-62. PubMed ID: 15176710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
    Bolukbas C; Bolukbas FF; Kebdir T; Canayaz L; Dalay AR; Kilic G; Ovunc O
    Acta Gastroenterol Belg; 2005; 68(4):432-4. PubMed ID: 16432996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection].
    Pohl J; Stremmel W; Kallinowski B
    Z Gastroenterol; 2000 Dec; 38(12):951-5. PubMed ID: 11194885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.
    Tahan V; Ozseker F; Guneylioglu D; Baran A; Ozaras R; Mert A; Ucisik AC; Cagatay T; Yilmazbayhan D; Senturk H
    Dig Dis Sci; 2003 Jan; 48(1):169-73. PubMed ID: 12645805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of pulmonary sarcoidosis induced by interferon alfa treatment in a female patient with hepatitis C].
    Vallina E; García Díez A; Gallego M; Villaverde P; Rippe ML; Arribas JM
    An Med Interna; 2000 Oct; 17(10):538-9. PubMed ID: 11109649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
    Chiang CH; Lai FJ
    J Formos Med Assoc; 2014 Dec; 113(12):981-2. PubMed ID: 25187070
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary sarcoidosis--a rare complication of interferon treatment for chronic hepatitis C].
    Pellová A; Pella J; Schréter I; Somos A; Kristian P; Boom A
    Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):200-2. PubMed ID: 17080355
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature].
    Alfageme Michavila I; Merino Sánchez M; Pérez Ronchel J; Lara Lara I; Suárez García E; López Garrido J
    Arch Bronconeumol; 2004 Jan; 40(1):45-9. PubMed ID: 14718122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
    Hurst EA; Mauro T
    Arch Dermatol; 2005 Jul; 141(7):865-8. PubMed ID: 16027302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
    Hoffmann RM; Jung MC; Motz R; Gössl C; Emslander HP; Zachoval R; Pape GR
    J Hepatol; 1998 Jun; 28(6):1058-63. PubMed ID: 9672184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M; Dainichi T; Gondo H; Urabe K
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients.
    Kasahara A
    J Gastroenterol; 2004 Nov; 39(11):1125-6. PubMed ID: 15580413
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous sarcoidosis limited to scars following pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Perez-Gala S; Delgado-Jimenez Y; Goiriz R; Fernandez-Herrera J; Fraga J; Garcia-Diez A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):393-4. PubMed ID: 17309467
    [No Abstract]   [Full Text] [Related]  

  • 20. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N; Aykin N; Demirdal T; Cevik F
    Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.